Author: Bayh-Dole Coalition
09 Feb HHS Backs NIH Rejection Of Xtandi Petition Despite March-In Framework
Gabrielle Wanneh
Inside Health Policy, 2/6/2024...
07 Feb Biden administration proposal would rob Pennsylvanians of new products
Lou Berneman
The Morning Call, 2/7/2024...
04 Feb Plan to lower drug costs may actually hurt U.S. legacy of innovation
Joseph P. Allen
Seattle Times, 2/4/2024...
28 Jan The Bayh-Dole Act works. It’s not time to change it.
Jon Soderstrom
Hartford Courant, 1/28/2024...
25 Jan Nobel prizes, cancer drugs and $280 million just part of Carol Mimura’s UC Berkeley legacy
Ron Leuty
San Francisco Business Times, 1/25/2024...
24 Jan Don’t punish small business heroes behind pandemic response
Jennifer C. Cheng
The Mercury News, 1/24/24
Also published in the East Bay Times and the Greeley Tribune...
23 Jan Protect Future Discoveries By Rejecting The TRIPS Patent Waiver
Lindsay Androski
International Business Times, 1/23/24...
22 Jan In ‘march-in’ rights, some see a tool to lower drug prices. Others see a threat to intellectual property
Ed Silverman
STAT, 1/22/24...